Ina Ambiel

1.2k total citations · 1 hit paper
12 papers, 789 citations indexed

About

Ina Ambiel is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Ina Ambiel has authored 12 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Virology, 6 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in Ina Ambiel's work include HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (4 papers) and Immune Cell Function and Interaction (4 papers). Ina Ambiel is often cited by papers focused on HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (4 papers) and Immune Cell Function and Interaction (4 papers). Ina Ambiel collaborates with scholars based in Germany, United States and United Kingdom. Ina Ambiel's co-authors include Oliver T. Keppler, O. Fackler, Frank Rutsch, Baek Kim, Renate König, Xiaoyu Pan, Manja Burggraf, Elina Erikson, Kristína Schenková and Thomas Gramberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Ina Ambiel

11 papers receiving 785 citations

Hit Papers

SAMHD1 restricts HIV-1 infection in resting CD4+ T cells 2012 2026 2016 2021 2012 100 200 300 400

Peers

Ina Ambiel
Mark T. Liddament United States
Viraj Kulkarni United States
Ashley P. Barry United States
Ina Ambiel
Citations per year, relative to Ina Ambiel Ina Ambiel (= 1×) peers Nadine Tibroni

Countries citing papers authored by Ina Ambiel

Since Specialization
Citations

This map shows the geographic impact of Ina Ambiel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ina Ambiel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ina Ambiel more than expected).

Fields of papers citing papers by Ina Ambiel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ina Ambiel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ina Ambiel. The network helps show where Ina Ambiel may publish in the future.

Co-authorship network of co-authors of Ina Ambiel

This figure shows the co-authorship network connecting the top 25 collaborators of Ina Ambiel. A scholar is included among the top collaborators of Ina Ambiel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ina Ambiel. Ina Ambiel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Aschenbrenner, Sabine, Felix Bubeck, Michael Jendrusch, et al.. (2025). A versatile anti-CRISPR platform for opto- and chemogenetic control of CRISPR-Cas9 and Cas12 across a wide range of orthologs.. PubMed. 53(14).
2.
Ambiel, Ina, Thorsten G. Müller, Paul R. Wratil, et al.. (2024). Spatial resolution of HIV-1 post-entry steps in resting CD4 T cells. Cell Reports. 43(3). 113941–113941. 6 indexed citations
3.
Stanifer, Megan L., Sarah R. Leist, Bettina Stolp, et al.. (2022). Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV/RNAi expression vectors. Molecular Therapy. 30(5). 2005–2023. 14 indexed citations
4.
Stolp, Bettina, Marcel Stern, Ina Ambiel, et al.. (2022). SARS-CoV-2 variants of concern display enhanced intrinsic pathogenic properties and expanded organ tropism in mouse models. Cell Reports. 38(7). 110387–110387. 31 indexed citations
5.
Berger, Arthur, Maximilian Muenchhoff, Marhild Kortenbusch, et al.. (2020). Severe underquantification of HIV-1 group O isolates by major commercial PCR-based assays. Clinical Microbiology and Infection. 26(12). 1688.e1–1688.e7. 4 indexed citations
6.
Stolp, Bettina, Nikolaos Tsopoulidis, Ina Ambiel, et al.. (2018). HIV-1 Nef Disrupts CD4+ T Lymphocyte Polarity, Extravasation, and Homing to Lymph Nodes via Its Nef-Associated Kinase Complex Interface. The Journal of Immunology. 201(9). 2731–2743. 11 indexed citations
7.
Ambiel, Ina, Manja Burggraf, Gina M. Lenzi, et al.. (2017). Vpx overcomes a SAMHD1-independent block to HIV reverse transcription that is specific to resting CD4 T cells. Proceedings of the National Academy of Sciences. 114(10). 2729–2734. 43 indexed citations
8.
Erikson, Elina, Paul R. Wratil, Martin Frank, et al.. (2015). Mouse Siglec-1 Mediates trans-Infection of Surface-bound Murine Leukemia Virus in a Sialic Acid N-Acyl Side Chain-dependent Manner. Journal of Biological Chemistry. 290(45). 27345–27359. 29 indexed citations
9.
Pan, Xiaoyu, Elina Erikson, Sarah Schmidt, et al.. (2012). SAMHD1 restricts HIV-1 infection in resting CD4+ T cells. Nature Medicine. 18(11). 1682–1688. 460 indexed citations breakdown →
10.
Pfeiffer, Tanya, Ina Ambiel, Yongkun Yang, et al.. (2012). Conformation‐specific Display of 4E10 and 2F5 Epitopes on Self‐assembling Protein Nanoparticles as a Potential HIV Vaccine. Chemical Biology & Drug Design. 80(3). 349–357. 76 indexed citations
11.
Tervo, Hanna-Mari, Stefanie Homann, Ina Ambiel, et al.. (2011). β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release. Retrovirology. 8(1). 9–9. 54 indexed citations
12.
Goffinet, Christine, Stefanie Homann, Ina Ambiel, et al.. (2010). Antagonism of CD317 Restriction of Human Immunodeficiency Virus Type 1 (HIV-1) Particle Release and Depletion of CD317 Are Separable Activities of HIV-1 Vpu. Journal of Virology. 84(8). 4089–4094. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026